A Study Evaluating Different Immunotherapies (LAG-3 and PD-1 With or Without TIGIT, Compared to PD-L1 Alone) in Participants With Untreated Locally Advanced Metastatic Urothelial Cancer
Clinical trial NCT05645692 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05645692
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-13
- Primary completion
- 2026-12-31
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.